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ABSTRACT  The  small  nuclear  RNAs are  known  to  be  complexed  with  proteins  in  the  cell 
(snRNP). To  learn  more  about these  proteins, we developed  an  in vitro system  for studying 
their interactions with individual small  nuclear RNA species. Translation of HeLa cell  poly(A) ÷ 
mRNA  in  an  exogenous  message-dependent  reticulocyte  lysate  results  in  the  synthesis of 
snRNP proteins. Addition of human small  nuclear RNA U1 to the translation products leads to 
the  formation  of  a  UI  RNA-protein  complex  that  is  recognized  by  a  human  autoimmune 
antibody specific for  U1  snRNP. This  antibody does  not react  with free  Ul  RNA. Moreover, 
addition of a 10- to 20-fold  molar excess of transfer RNA instead of U1  RNA does  not lead to 
the formation of an antibody-recognized RNP. The proteins forming the specific complex with 
U1 RNA correspond to the A, Bt, and B2 species (32,000, 27,000, and 26,000 mol wt, respectively) 
observed  in  previous studies with  UI  snRNP obtained  by antibody-precipitation  of  nuclear 
extracts. The availability of this in vitro system now permits, for the first time, direct analysis of 
snRNA-protein  binding  interactions  and,  in  addition,  provides  useful  information  on  the 
mRNAs for snRNP proteins. 
The small nuclear RNAs (snRNAs) are stable, abundant RNA 
species  present  in  a  wide  spectrum  of eucaryotic organisms 
from insects to humans (15). There is evidence that at least one 
snRNA, UI, may be involved in some aspect of RNA process- 
ing, perhaps mRNA spicing. This hypothesis is supported by 
the  facts  that  a  sequence  near  the  5'  end  of UI  RNA  is 
potentially complementary to splice junctions  (1,  8,  10,  16), 
that  U I  RNA is hydrogen-bonded to heterogeneous nuclear 
RNA  in  vivo  (3),  and  that  adenovirns  mRNA  splicing  is 
inhibited when isolated nuclei are incubated with an antibody 
to U 1 RNA-containing ribonucleoprotein particles (22). 
The small nuclear RNAs are complexed with proteins in the 
cell (13,  18). It has recently been discovered that patients with 
autoimmune  diseases  such  as  systemic lupus  erythematosus 
and mixed connective tissue disease often produce circulating 
antibodies against snRNA-protein complexes, or snRNPs (5, 
9).  One class of such antibodies, termed anti-Sm, precipitates 
snRNP  complexes  containing  the  five  major,  nonnucleolar 
snRNAs:  UI,  U2,  U4,  U5, and  U6.  Other patients  produce 
antibodies, termed anti-RNP, which are essentially monospe- 
cific for U 1 snRNP (9, 20, 21). 
It is  likely that these snRNA-protein complexes represent 
the functional forms of the snRNAs in vivo. The proteins may 
be enzymes important  in  RNA processing,  as in the case of 
RNAse P, an Escherichia coli tRNA processing enzyme that is 
known to be a  ribonucleoprotein complex (7).  Alternatively, 
snRNP proteins may serve primarily a structural role, perhaps 
analogous to ribosomal proteins, which form a surface condu- 
cive to short RNA base-pairing interactions (codon:anticodon). 
It seems likely that understanding the function(s) of snRNPs 
will depend, at least in part, on defining the proteins that are 
bound to each of the individual snRNA species. In this paper 
we present a new approach to this problem. Cell-free transla- 
tion of snRNP proteins and the use of autoimmune antibodies 
are  combined  to  examine  specific  protein  binding  sites  on 
snRNAs in vitro. 
MATERIALS  AND  METHODS 
Purification of snRNP and snRNAs:  The isolation and analysis 
of snRNPs from log phase HeLa cell nuclei using IgG isolated from the sera of 
patients with autoimmune disease has been described previously in detail (20). 
snRNAs were recovered from antibedy-selected snRNPs by phenol extraction 
and, where necessary, were further purified by electrophoresis in 10% polyacryl- 
amide-7 M urea gels containing 50 mM Tris-borate, pH 8.3. Individual snRNA 
bands were visualized by brief staining with ethidium bromide, excised from the 
gel, and recovered by electroelution. 
sngNA-protein  Binding  In  Vitro:  mRNA  was prepared from 
HeLa cell cytoplasm by the guanidine-HCl-cesium chloride technique as de- 
scribed in detail previously (19) and was fractionated on oligo(dT)-cellulose. The 
mRNA-dependsnt rabbit reticulocyte lysate was prepared according to Pelham 
and  Jackson (12)  and  was supplemented with 50 /~g/ml calf thymus tRNA 
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For snRNA-protein binding in vitro, 3.5-5.0 #g of polyadanylated RNA were 
added to  115 #1 of the mRNA-depandant reticulocyte lysate. After t h at 30°C, 
10-200  ng of purified snRNA or 1/~g of tRNA was added to the lysate, and the 
sample was incubated for an additional hour at 30°C. The translation-binding 
reactions were then chilled to 4°C,  1 M  Tris-HC1,  pH 8.5, was added to a final 
concentration of 10 raM, and 25 ~tg of the appropriate antibody or nonimmune 
IgG was added.  After 30  min at 4°C,  protein  A-Sepharos¢ was added,  then 
washed with 0.15 M NaC1, 5 mM EDTA, 0.5% Nonidet P-40,  50 mM Tris-HC1, 
pH 7.5, and the antibody-antigan complexes were eluted with 0.1 M glycine-HC1, 
pH 3.0, as described in detail previously (20). 
We first  examined  the  presence of endogenous rabbit  U1 
snRNP in the lysate itself.  After addition of human anti-RNP 
antibody  to  an  aliquot  of lysate,  followed  by  selection  on 
protein  A-Sepharose  and  elution,  RNA  was  extracted  and 
analyzed  by gel  blot  hybridization  with  chicken  UI  DNA 
probe. This probe hybridizes specifically with rabbit UI RNA 
RESULTS 
Antibody Specificities 
The properties of human autoimmune antibodies reactive 
for nuclear RNA antigens, including snRNPs, have been de- 
scribed  (5,  9,  20).  The snRNP  speciticities  of the  particular 
antibodies used in this investigation are shown in Fig. 1. HeLa 
cells  were  labeled  with  [3H]uridine  or  [~S]methionine,  and 
nuclear extracts were reacted with either anti-RNP or anti-Sm 
antibodies.  Lanes  2  and  3  in  Fig.  1 show the  RNA species 
present in the RNP selected by anti-RNP and anti-Sm, respec- 
tively. Only U1 RNA-containing RNP is selected by anti-RNP, 
whereas anti-Sin selects RNPs containing U 1, U2, U4, U5, and 
U6. None of these RNAs are selected from HeLa cell nuclear 
extracts by nonimmune IgG (20). As shown in lanes 5 and 6, 
both antibodies  select  a  similar  set  of eight  proteins  having 
molecular  weights  between  32,000  ("A")  and  10,000  ("F"). 
These  proteins  are not selected  by nonimmune IgG (Fig.  1, 
lane  4).  Anti-RNP, as its name implies,  does not react with 
deproteinized  U1  RNA or to an appreciable extent with free 
snRNP proteins (data not shown). This forms the basis for its 
use in the experiments to be described here. 
Formation of Antigenically Active snRNP 
In Vitro 
The experimental approach is shown in Fig. 2. HeLa cell 
poly(A)  + messenger RNA is  translated  into  [35S]methionine- 
labeled protein in an exogenous mRNA-dependent rabbit re- 
ticulocyte lysate (12).  U1 RNA or other purified snRNAs are 
then added, and their assembly into RNP complexes is moni- 
tored by the appearance of both the snRNA and specific aSS- 
labeled proteins in antibody-recognizable structures. 
FIGURE 1  Specificities  of  the  anti-RNP  and  anti-Sm  antibodies. 
HeLa cells were labeled for 22 h with either [aH]uridine (lanes 1-3) 
or [35S]methionine (lanes 4-6). Nuclear extracts were reacted with 
antibody as designated. Lanes 1-3: fluorographs of 3H-RNA electro- 
phoresed  in  10%  polyacrylamide  gels containing  98%  formamide 
and 40 mM sodium  phosphate, pH 7.0. Lanes 4-6: fluorographs of 
[35S]methionine-labeled proteins electrophoresed in 11% SDS poly- 
acrylamide gels. Lane 1: Total snRNAs from HeLa cells. Lane 2: RNA 
selected by anti-RNP. Lane 3:  RNA  selected by anti-Sin.  Lane 4: 
Proteins selected by  control  (nonimmune)  IgG. Lane 5:  Proteins 
selected by anti-RNP. Lane 6: Proteins selected by anti-Sm. Proteins 
are  designated  as  A-G  according  to  Lerner and  Steitz  (9). We 
occasionally find that the lowest molecular weight protein  runs as 
a doublet in this gel system (presumably  F plus G). Accordingly, we 
designated this band as F, G in the figures, but for simplicity refer to 
it as Fin the text. 
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highly conserved (2). As can be seen in lane I of Fig. 3, a small 
amount of  endogenous U1 RNA is indeed present in the lysate. 
This  rabbit  U1  RNA  must  be  in  RNP  form  because,  as 
described above, the human anti-RNP antibody does not react 
with protein-free  U1  RNA. Lane 2 in Fig.  3 shows that the 
endogenous U 1 RNA is not selected from the lysate by non- 
immune human IgG. 
The reticulocyte lysate apparently also contains endogenous 
proteins capable of binding to exogenous U1 RNA, as shown 
by the greatly increased U 1 blot hybridization signal observed 
when human UI RNA is added (Fig. 3, lane 3). None of the 
added human U I RNA is recovered from the lysate by non- 
immune human IgG (Fig. 3, lane 4). The fact that this exoge- 
nous  U l:endogenous protein  complex is recognized by anti- 
RNP antibody suggests that the participating  rabbit proteins 
are antigenically the same as those that are normally bound to 
human  U I  RNA.  The  f'mding that  the  reticulocyte  lysate, 
which  is  a  cytoplasmic fraction,  contains  U I  RNA-binding 
proteins concurs with the results of a recent study demonstrat- 
ing that UI RNA microinjected into enucleated Xenopus oo- 
cytes forms RNP structures that are recognized by anti-RNP 
antibody (4). 
Fig.  4  shows  that  snRNP  proteins  are  synthesized  when 
HeLa cell poly(A)  + messenger RNA is translated in the retic- 
ulocyte lysate. Lane 2 in Fig. 4 shows the in vitro synthesized 
[35S]methionine-labeled  proteins  that  are  selected  from  the 
translated  lysate by anti-Sm antibody following the addition 
of small  nuclear RNAs U 1,  U2, and U4-U6.  It can be seen 
that the proteins synthesized correspond in molecular weight 
FIGURE 4  [3%]Methionine-labeled HeLa proteins selected by anti- 
Sin.  Lane  1: Proteins selected  by anti-Sin from  the nuclei of  HeLa 
cells labeled for 22 h with  [35S]methionine. Lane 2: In vitro-synthe- 
sized  proteins selected  by anti-Sin  from  a  reticulocyte lysate pro- 
grammed with  HeLa cell  poly(A) +  mRNA  and supplemented with 
HeLa U1,  U2,  U4,  US, and  U6  RNAs.  Lane  3:  Proteins selected  by 
anti-Sm from  the cytoplasmic fraction of HeLa cells labeled for 30 
rain with  [S%]methionine. Mr (X 10  -3) are designated to the left of 
lane  1. The high molecular weight proteins (>35,000) present in this 
sample  are  also selected  from  HeLa cytoplasm  by control  serum 
(data not shown). 
FIGURE  3  Assembly of  purified  human  UI  RNA and endogenous 
proteins  in  the  nontranslated  rabbit  reticulocyte  lysate.  UI  RNA 
(lanes 3 and  4) or tRNA  (lanes  1 and  2) were added to an mRNA- 
dependent reticulocyte lysate in the absence of exogenous mRNA. 
After 60 min  at 30°C, antibody selected  RNAs were prepared and 
electrophoresed in a  10% polyacrylamide-7 M  urea gel containing 
50 mM Tris-borate, pH 8.3. Following electrophoretic transfer of the 
RNA  to  DBM  paper,  the  blot  was  hybridized  with  a  32P-labeled 
chicken Ul DNA clone (3, 17). Lanes  I and 3: RNA selected by anti- 
RNP.  Lanes  2  and  4:  RNA selected  by control  (nonimmune)  IgG. 
Lane 5 contains cytoplasmic RNA  isolated from  reticulocyte lysate 
and labeled in vitro with ~2P-pCp  and T4 RNA ligase. 
to  the  in  vivo-labeled  nuclear  proteins  selected  by  anti-Sm 
(Fig. 4, lane I). Noteworthy in the in vitro translation pattern 
(Fig. 4, lane 2) is the relatively reduced amounts of A protein, 
the relatively increased amounts of the D-G proteins, and the 
almost total  absence  of C  protein.  It is  of interest  that  this 
pattern is qualitatively very similar to that of proteins selected 
by anti-Sin from HeLa cytoplasm labeled with [aSS]methionine 
for 30 rain (Fig. 4, lane 3), where again the A and C proteins 
are reduced and D-G increased relative to the nuclear pattern. 
When HeLa cell messenger RNA is translated in the retic- 
ulocyte lysate, subsequent addition of U 1 RNA results in the 
formation of a  RNA-protein complex that is specifically rec- 
ognized by anti-RNP antibody. This U 1 RNA-protein complex 
(Fig. 5, lane 2) contains three newly translated proteins, with 
molecular weights of  32,000, 27,000, and 26,000. These proteins 
correspond in molecular weight to the A, BI, and B2 proteins 
found in vivo. As can be seen in lane 1 of Fig. 5, small amounts 
of these three proteins are recognized by the antibody without 
the addition of U 1 RNA. This may reflect a low reactivity of 
the antibody for free proteins or, more likely,  may be due to 
the small amount of U 1 RNA present in the HeLa messenger 
RNA  preparation  used  to  program  translation  (data  not 
shown). The absence of the C-F proteins from the U 1 RNP 
complex  (Fig.  5,  lane  2)  is  not  due  to  their  failure  to  be 
synthesized in the lysate, because they are readily detected by 
selection with anti-Sm antibody (Fig. 4), which recognizes free 
proteins as well as snRNP complexes (5). 
The remote possibility that the presence of U 1 RNA simply 
stabilizes these three proteins in the reticulocyte lysate is ex- 
amined in the experiment shown in Fig. 6, where an excess of 
unlabeled methionlne was added to the translation system after 
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nine-labeled  proteins  synthesized  in  vitro 
with purified U1 RNA. tRNA (lane 1) or anti- 
RNP  antibody-purified,  phenol-extracted 
U1  RNA  (lane 2)  was added to [35S]methi- 
onine labeled proteins that  had  been syn- 
thesized in a rabbit reticulocyte lysate pro- 
grammed  with  HeLa cell  poly(A) +  mRNA. 
Antigenically  active  U1  RNP:protein  com- 
plexes  that  assembled  in  vitro  were  re- 
covered with anti-RNP. 
FIGURE 6  Stability  of  [35S]- 
methionine  labeled  proteins 
binding  to U1  RNA in the re- 
ticulocyte lysate. HeLa mRNA 
was  translated  in  an  mRNA- 
dependent reticulocyte  lysate 
in the presence of [35S]methi- 
onine. Lanes I and 2: HeLa U1 
RNA (lane  7) or tRNA (lane 2) 
were added to aliquots of  reticulocyte  lysate at the  beginning of 
translation. After 45 min at 30°C, samples were chilled to 4°C and 
adjusted  to pH  8.5.  Antigenically active RNP complexes were iso- 
lated  with  anti-RNP.  Lanes  3  and  4:  After  an  initial  45  rain  of 
translation in the absence of added snRNA,  unlabeled methionine 
was added to a final concentration of 100/zM (20-fold excess of total 
methionine).  After  another 45  rain  at 30°C,  U1  RNA  (lane  3)  or 
tRNA (lane 4) was added, and the incubation was continued for a 
final 45-rain interval. Samples were then chilled to 4°C and adjusted 
to pH  8.5.  AntigenicaUy active RNP complexes were isolated with 
anti-RNP.  The  exposure time for  this  fluorogram  was  selected  to 
ensure that the  band of  A  protein was  in the linear range of the 
dpm-grain exposure curve. 
45 rain of translation in the presence of [~S]methionine. After 
a further 45 rain of incubation to permit the postulated decay 
of  the radioactive snRNP proteins synthesized during the initial 
incubation, U1 RNA (Fig. 6, lane 3) or tRNA (Fig. 6, lane 4) 
was  added.  After  an  additional  45  min~ U1  RNA:protein 
complexes were isolated with anti-RNP antibody. No reduction 
in  the  intensity  of the  A  or B  protein  bands  was  observed 
relative to a sample in which UI RNA was added for the in'st 
45  min  of translation  (Fig.  6,  lane  1).  Hence  the  specific 
interaction between U1 RNA and these three proteins does not 
require the presence of UI RNA at the time the proteins are 
synthesized. 
DISCUSSION 
The  formation  of antigenically  active  snRNA-protein com- 
plexes  in  vitro  provides  a  new approach  to the  analysis  of 
snRNP structure. When mRNA is translated in the reticulocyte 
lysate, subsequently added UI RNA specifically interacts with 
the newly synthesized proteins  in  a  manner  that  creates an 
antigenic site reco£nized by the anti-RNP antibody. The UI 
RNA-protein complex assembled in vitro contains only three 
1754  THE JOURNAL  OF CELL  BIOLOGY •  VOLUME  96, 1983 
of the eight proteins found associated with UI RNA in vivo. 
Thus, the five smallest snRNP proteins identified in vivo are 
apparently not required for the formation of the antigenic site 
recosniTed by this antibody. The three proteins which do bind 
to U1 under these conditions comigrate with the A, BE, and B2 
proteins identified in vivo, and we suspect that they are iden- 
tical to them. It is noteworthy that the in vitro assembly of an 
antigenically active U1 RNA-protein complex apparently does 
not require the short-lived, cytoplasmic precursor form of U 1 
RNA  identified  previously  (6,  23).  In addition,  our  results 
establish that at least some assembly of snRNP can occur in a 
specific manner in vitro in the absence of defined organelles or 
cellular  architecture.  Nor does in  vitro  assembly of snRNP 
from  newly  synthesized  protein  require  deliberate 
"reconstitution" conditions such as the use of protein denatu- 
rants  followed  by  slow  reassociation  of protein  and  RNA 
during dialysis.  Finally,  our results  are  compatible with the 
possibility that at least the initial steps in snRNP assembly in 
vivo occur in the cytoplasm (Madore, Wieben, and Pederson, 
manuscript submitted for publication; see also reference 4). 
The approach we have developed provides new information 
about the mRNAs for snRNP proteins. The mRNAs for the A, 
B1,  and  B2  snRNP  proteins  contain  poly(A)  (Fig.  5).  (The 
poly(A)- HeLa cytoplasmic RNA fraction has not been ex- 
amined in detail, and therefore we cannot state whether or not 
these  mRNAs  are  also  present  in  the  poly(A)-  [oligo(dT)- 
nonbound] fraction.) Expe.  riments with sucrose gradient-frac- 
tionated poly(A)  ÷ mRNA indicate that the mRNAs for the A, 
B1, and B2 proteins sediment at 15-20S and comprise 0.1-0.3% 
of the total HeLa cell poly(A)  ÷ mRNA (unpublished results). 
It has been reported that U1 RNA inhibits protein synthesis 
in a wheat germ cell-free system (14). We find no such effect 
when the amounts of [~S]methionine incorporation are com- 
pared in lysates run with HeLa poly(A)  + mRNA plus or minus 
added  U1  RNA  (data  not  shown).  It  is  possible  that  the 
concentrations of U1  we employed are below those required 
for the previously reported effect (14). 
While the U1 RNA-dependent recognition of the A, B1, and 
B2 proteins in vitro constitutes a  more rigorous identification 
of these proteins as being UI RNA-associated than co-precip- 
itation  with  a  polydonal antiserum,  we have  at  present  no 
reason to doubt that the five smaller proteins are also authentic 
components  of U1  snRNP  in  vivo.  It  is  probable  that  the 
assembly of UI snRNP in this system is incomplete. Although 
the  reasons  for this  are not understood  at present,  we have 
been able to rule out the trivial possibility that the C~, C2, D, 
E, and F proteins are not synthesized in the reticulocyte lysate. 
Experiments using Sm antibody, which reco~rni~es free proteins 
as well as snRNA-protein complexes, confirm that  all  eight 
snRNP proteins are synthesized in the lysate (Fig. 4). Further- 
more, these proteins (Fig. 4, lane 2) are produced in amounts 
that approximate their relative abundance in the cytoplasm of 
HeLa ceils after a short labeling period in vivo (Fig. 4, lane 3). 
Complete assembly of snRNP in vitro might require the use of 
the precursors of snRNAs, co-factors not present in the retic- 
ulocyte lysate, or simply adjustments of the salt and tempera- 
ture  conditions  used  for  assembly.  Such  factors  have  been 
shown to be very significant in the reconstitution of ribosomes 
from purified components (11). 
The  fact  that  specific binding  of proteins  to  snRNA can 
occur in vitro opens the way for a more detailed analysis of the 
structure and assembly of  snRNP than was heretofore possible. 
For example,  the  use  of this  procedure  with  other  snRNA species or defined snRNA fragments should lead to an under- 
standing of the parameters regulating the assembly of snRNP, 
the proteins unique to individual snRNAs as opposed to ones 
common to all species (21), and the relative contributions of 
protein-RNA  vs.  protein-protein  interactions.  The  in  vitro 
assembly approach also provides a  way of screening cDNA 
clone banks for snRNP protein mRNAs, after message selec- 
tion. Such experiments are now in progress. 
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